The audience for this course is limited to clinicians who wish to provide HIV treatment or who are currently providing treatment. This includes physicians, nurse practitioners, physician assistants, pharmacists, nurses and dentists.

This extensive three day HIV clinical training program consists of two virtual didactic days on Monday and Tuesday May 9-10 and one in-person clinical training day on Wednesday or Thursday, May 11 or 12 or 18, 2022

On the first two days will be virtual and feature expert faculty who will discuss cutting-edge HIV topics such as outpatient management, antiretroviral use, clinical use of resistance assays, and co-morbidities (including Hepatitis C, cardio vascular disease and STIs) management of women, perinatal transmission, psychosocial, substance use and legal issues. 

The third day will be in -person on Wednesday or Thursday May 11 or 12 or 18, 2022 from 8:15 am to 2:45pm. . The in person observation will be spent in Drexel University College of Medicine’s Division of Infectious Diseases and HIV Medicine HIV service, Partnership Comprehensive Care Practice.

Questions:  Call Susan Thompson@267-847-6396

CME Program Code: 22251

TARGET AUDIENCE: Physicians, nurse practitioners, nurses, physician assistants, dentists, pharmacists, and emergency medical services professionals

LEARNING OBJECTIVES: Participants will be able to:

Describe the medical management of HIV

Discuss what medications to initiate and the role of resistance testing

Identify legal parameters that need to be met when providing HIV testing or care

Recognize treatment options for HCV in the patient with HIV

Describe HIV testing technology and HIV testing and special issues in treating adolescents

Discuss the role of nPEP/PrEP in HIV care

Identify cardiovascular complications of HIV and their ramifications for treatment

Differentiate care issues unique to women

Illustrate nutritional challenges for patients with HIV

Examine the interaction of STIs on the treatment and prevention of HIV infection

Examine trauma informed care as a way to address stigma and retention in care

Explain the role of medically assisted treatments for patients with substance use disorder

Explain strategies to address nicotine addiction and assist smokers in quitting

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Drexel University College of Medicine and the MidAtlantic AIDS Education and Training Center of the Health Federation of Philadelphia. The Drexel College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA: This program is eligible for 16.00 credits in Category 2A of the American Osteopathic Association.

NURSING STATEMENT: This nursing educational program is jointly provided by The Association of Nurses in AIDS Care (ANAC) and the MidAtlantic AIDS Education and Training Center of the Health Federation of Philadelphia. ANAC is providing 16.00 contact hours for the successful completion of this program. ANAC is accredited as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation. To claim nursing contact hours, attendees must:

• Be registered as a participant.
• Be present during the online participant check-in and for the duration of the activity
• Complete the post training evaluation.

A link to an online survey will be emailed to you after the training. Complete and submit the online survey. The last step of the survey will allow you to download and print a certificate of completion. The deadline to claim contact hours is June 30, 2022

Individuals in a position to control the content of this educational program are required to disclose all relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Any relevant financial relationships must be mitigated by ANAC prior to the presentation and announced to the audience. Presenters will announce any disclosures prior to their educational session. NCPD planning committee members Julie Schexnayder, DNP, PhD, MPH, ACNP-BC, Kristin Walker RN, MSN, CNM, and Lane Taylor MPH have no relevant financial relationships with ineligible companies to disclose.

FACULTY DISCLOSURE STATEMENT

It is the policy of Drexel University College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience, any relevant commercial interest (which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation.

FACULTY DISCOSURES: David Koren, PharmD, BCPS, AAHIVP is on the advisory committee for Gilead Sciences, ViiV and Thera Technologies, He also disclosed, he is an independent contractor for Thera Technologies and Abbvie. Joanne Gilmore, MSN, CRNP is on the speaker’s bureau for Gilead Sciences and Abbvie. Roberta Laguerre, MD is on the speaker’s bureau for Gilead Sciences. William Short MD, MPH is a consultant for Viiv and receives an honorarium for Janssen and Vii. Helena Kwakwa, MD, MPH, institution has received a grant from ViiV. They attest that clinical recommendations are evidence based and free of commercial bias. Susan Thompson, BS, Amy Althoff, MD, Lenore Asbel, MD, Ellen Tedaldi MD, Margaret Cauterucci, RD, Leah McCurdy MSN, CRNP, FNP-C, RN-BC, Yolanda French Lollis, Esq., and Marcy Witherspoon, MSW, LSW have no commercial relationships to disclose.

PLANNING COMMITTEE DISCLOSURES: Jennifer Kolker, MPH, Amy Althoff, MD, and Susan Thompson BS have no relationships to disclose.

Requirements to receive credits: Continuing education credits will be awarded to those who registered for the program, attend the entire program, complete the discipline-specific requirements and program evaluation.

ACKNOWLEDGEMENT:

Supported by a grant from the Health Resources and Services Administration (HRSA),

HIV/AIDS Bureau, Office of Program Support, No. U1OHA29295